Cardiology Topic Homepage
Cardiology Overview
In 2008, cardiovascular diseases (CVD) were responsible for 17.3 million deaths worldwide - almost a third of global deaths. However death rates vary worldwide with the low and middle-income countries representing 80% of these deaths.1
In Europe Coronary Heart Disease and Stroke have the highest death rates killing 1.92 million and 1.24 million respectively each year.2
The death rate from CVD has...
On the other hand, the death rate has increased in Central and Eastern Europe for example the death rate in men under 65 years increased by 57% and 19% in Albania and Ukraine respectively between 1994 and 2004. The trend is the same for women under 65 years in these countries with a 46% and 19% increase respectively within the period.2
Diseases of the cardiovascular system include hypertension,acute coronary syndrome or ACS, heart failure , stroke, cardiac arrhythmias, cardiac conduction defect, pericarditis, congenital heart disease, cardiac valvulopathy and venous thromboembolism.3
Although hypertension is a CVD, it's also a risk factor for other CVD. The risk of developing subsequent CVD is higher with more severe hypertension.4
Cardiac arrhythmias and cardiac conduction disorders are mainly represented by atrial fibrillation and bradycardia.5
Patients with atrial fibrillation are five times more likely to suffer a stroke, while those with either atrial fibrillation or myocardial infarction have an increased risk of heart failure.5
Acute Coronary Syndrome (ACS) and stroke are usually the end result of atherosclerosis -which is the most common cause of deaths in industrialised countries. Atherosclerosis is the formation of a plaque in the blood vessels. Its main components are LDL-cholesterol and its mechanism of formation is accurately described in both the Cholesterol and Heart Failure Knowledge Centres.
The main CVD modifiable risk factors are tobacco, excessive alcohol consumption, diet (salt and fat), physical inactivity, obesity, stress and diabetes. Usually, people combine several of these risk factors creating a synergic effect.3 By altering these lifestyle choices, 80% of cardiovascular diseases could be prevented.1
Some other risk factors are non modifiable such as, increased age, male gender and positive family history.3
There are two types of prevention: primary (to prevent atherosclerosis) and secondary (to prevent disease exacerbation).
Diagnostic techniques include blood pressure measurement, ECG, chest X-Ray, Echocardiography, cardiac catheterization, MRI and blood tests (K+, Cholesterol, Haemoglobin, natriuretic peptides).3
The treatment of CVD, can be divided in two categories. For ACS pharmacological management (e.g. statins) and non pharmacological management are available. For hypertension, the approach is similar, treated with both lifestyle and pharmacological intervention. The main goals of many CVD treatments are to lower LDL-C and blood pressure and prevent thrombus formation (anticoagulant agents).
References
- WHO, Fact Sheet N317 september 2011, available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html, accessed the 20th of September 2012
- The European Heart Network, European cardiovascular Statistics 2008 Edition available at: http://www.herzstiftung.ch/uploads/media/European_cardiovascular_disease_statistics_2008.pdf, accessed the 20th of September 2012
- Beers M.H. et al. The Merck manual of medical information. Merck research laboratories. Second home edition. 2003, 113-239
- NICE clinical Guideline, Hypertension Clinical Management of Primary Hypertension in Adults, August 2011, available at: http://www.nice.org.uk/nicemedia/live/13561/56008/56008.pdf, accessed the 20th of September 2012
- European Society of Cardiology, Guidelines for the Management of Atrial Fibrillation, 2010, available at: http://www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-afib-FT.pdf, accessed the 20th of September 2012
Content on this page
Drug News
RELY-ABLE trial shows long-term safety profile of Pradaxa (Boehringer) in patients with Atrial Fibrillation
16-06-2013Results from the RELY-ABLE trial, a long-term extension of the pivotal RE-LY study of Pradaxa (dabigatran etexilate), from Boehringer, in patients with non-valvular Atrial Fibrillation (NVAF),...
FDA approves Ellipse and SJM Assura ICDs and CRT-Ds (St Jude Medical) for Heart Failure
15-06-2013The FDA has approved the next-generation Ellipse and SJM Assura portfolio of implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), from St...
Phase III data on Gencaro (ARCA biopharma) shows drug effective on genetic subset of Atrial Fibrillation patients
08-06-2013New results of a Phase III trial of Gencaro (bucindolol hydrochloride), from ARCA biopharma, in reducing the incidence of new onset Atrial Fibrillation in patients with advanced heart failure with...
Cardiology Drug Data - A-Z
Possible searches include drugs or medicines (by brand, generic ingredient or drug class), diseases, conditions and more.
Recent Drug Updates
Omacor
13-06-2013Post Myocardial Infarction Adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy (e.g. statins, anti-platelet medicinal products, ...
Aprovel Film-Coated Tablets (sanofi-aventis Bristol-Myers Squibb SNC)
14-05-2013Aprovel is indicated in adults for the treatment of essential hypertension. It is also indicated for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus...
Ranexa prolonged-release tablets
08-05-2013Ranexa is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal...
Clinical Guidelines
Ivabradine for treating chronic heart failure
Nov 2012Ivabradine (Procoralan, Servier Laboratories) is a heart-rate-lowering agent that selectively and..
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Aug 2012The current estimate of the prevalence of atrial fibrillation (AF) in the developed world is..
Online CME
Giving Informed Advice on Coffee and Caffeine Intake
Apr 2013Plant sterols and cardiovascular risk
Apr 2013Clinical Trials
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
09-04-2013The aim of the study is to determine relevant hemodynamic parameters for the diagnostics of pulmonary arterial hypertension (PAH) by dynamic contrast enhanced dual-energy CT (DE-CT). In this prospective study the investigators validate DE-CT results of patients against hemodynamic parameters from right heart..
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
05-04-2013This is a randomized-controlled open-label trial comparing two different doses of low-molecular-weight heparin (LMWH) in pregnant patients with a history of previous venous thromboembolism (VTE). Both doses are recommended doses in the 2012 guidelines of the American College of Chest Physicians (ACCP), but it is not..
Medical Videos
Medical Journal Abstracts
Cardiopulmonary resuscitation in the pregnant patient: a manikin-based evaluation of methods for producing lateral tilt
Anaesthesia
May 2013
The importance of minimising aortocaval compression during cardiopulmonary resuscitation in late pregnancy is widely accepted. Current European guidelines suggest employing manual displacement of the uterus with left lateral tilt to achieve this. Several methods for producing lateral tilt have been described; however,..
Changes in cardiac index and blood pressure on positioning children prone for scoliosis surgery
Anaesthesia
May 2013
In this prospective observational study we investigated the changes in cardiac index and mean arterial pressure in children when positioned prone for scoliosis correction surgery. Thirty children (ASA 1–2, aged 13–18 years) undergoing primary, idiopathic scoliosis repair were recruited. The cardiac index and mean..
Medical Apps
Cardiac CT imaging - Diagnosis of Cardiovascular disease - £3.99
Cardio3 ECHO Lite - Free
Cardiology at hand - Free
ECG - £0.61
Social Media
ECG Quiz
on doc2docECG Quiz AF with Complete Heart Block.Dr.Chid
Frailty. Is it an important clinical syndrome?
on doc2doc... or the consequences of treating certain diseases like malignancies, cardiovascular disorders or stroke, rather than a separate syndrome. Management of ...
Frailty. Is it an important clinical syndrome?
on doc2doc... treatments, one should consider doses in patients with renal failure, heart failure, liver dysfunction, depressed immune system, undernourished ...

